GSK299423 - CAS 1352149-24-6
Catalog number:
1352149-24-6
Category:
Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C25H27N5O2S
Molecular Weight:
461.58
COA:
Inquire
Targets:
DNA/RNA Synthesis
Description:
GSK299423 is an antibiotic agent and it seems potentially effective in treating patients infected with bacteria expressing the New Delhi metallo-beta-lactamase. GSK299423 is a Type II bacterial DNA topoisomerase inhibitor under the development of GlaxoSmithKline. Early research for the treatment of Gram-negative infections and Nosocomial infections was on-going in USA.
Publictions citing BOC Sciences Products
  • >> More
Purity:
98%
Appearance:
Powder
Synonyms:
4-(2-(4-(([1,3]oxathiolo[5,4-c]pyridin-6-ylmethyl)amino)piperidin-1-yl)ethyl)-6-methoxyquinoline-3-carbonitrile
Solubility:
Soluble in DMSO
Storage:
-20°C Freezer
MSDS:
Inquire
Application:
Gram-negative infections; Nosocomial infections
Quality Standard:
In-house standard
Shelf Life:
2 month in rt, long time
Quantity:
Milligrams-Grams
InChIKey:
NKXJSCXEAVZSMF-UHFFFAOYSA-N
InChI:
1S/C25H27N5O2S/c1-31-20-2-3-23-22(11-20)21(17(12-26)13-29-23)6-9-30-7-4-18(5-8-30)27-14-19-10-25-24(15-28-19)32-16-33-25/h2-3,10-11,13,15,18,27H,4-9,14,16H2,1H3
Canonical SMILES:
COc1ccc2c(c1)c(c(cn2)C#N)CCN3CCC(CC3)NCc4cc5c(cn4)OCS5
Current Developer:
Defense Threat Reduction Agency; GlaxoSmithKline
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related DNA/RNA Synthesis Products


CP 115953
(CAS: 136440-70-5)

CP 115953 is a Type II DNA topoisomerase inhibitor originated by Pfizer. CP 115953 inhibits topoisomerase II activity via an interaction with the enzyme and not...

CAS 81424-67-1 Caracemide

Caracemide
(CAS: 81424-67-1)

Caracemide is an agent derived from acetohydroxamic acid. It has potential antineoplastic activity. Caracemide can inhibit ribonuclease reductase, resulting in ...

TH287 hydrochloride
(CAS: 1638211-05-8)

TH287 hydrochloride, with potent anti-cancer property, is a novel inhibitor of the MTH1 protein which is required for cancer cell survival and is overexpressed ...

GSK299423
(CAS: 1352149-24-6)

GSK299423 is an antibiotic agent and it seems potentially effective in treating patients infected with bacteria expressing the New Delhi metallo-beta-lactamase....

CAS 87434-82-0 Dezaguanine Mesilate

Dezaguanine Mesilate
(CAS: 87434-82-0)

Dezaguanine is a new antipurine antimetabolite. Dezaguanine is a DNA synthesis inhibitor. It has significant activity against transplantable rodent solid tumors...

CAS 113942-30-6 Temozolomide Acid

Temozolomide Acid
(CAS: 113942-30-6)

Temozolomide acid is an active metabolite of temozolomide(T017775) with anticancer activity in vitro. Temozolomide is an alkylating agent used as a treatment of...

Tinostamustine Hydrochloride
(CAS: 1793059-58-1)

The hydrochloride salt form of Tinostamustine, a benzimidazol derivative, has been found to be a HDAC inhibitor and could probably be effective against sorts of...

CAS 127759-89-1 Lobucavir

Lobucavir
(CAS: 127759-89-1)

Lobucavir is a RNA-directed DNA polymerase inhibitor originated by Bristol-Myers Squibb as a nucleoside analog. Treatment for Cytomegalovirus infections, Hepati...

Doravirine
(CAS: 1338225-97-0)

Doravirine is a non-nucleoside reverse transcriptase inhibitor under development of Merck & Co. IC 50 value is 12 nM against the wild type, 21nM against K103N, ...

CAS 841301-32-4 Amenamevir

Amenamevir
(CAS: 841301-32-4)

Amenamevir is a DNA helicase-primase inhibitors. It has anti-HSV activity against herpes simplex keratitis. In Mar 2016, Mahuro completed a phase III trial in H...

TH287
(CAS: 1609960-30-6)

TH287 is a potent and selective MTH1 (NUDT1) inhibitor with IC50 of 0.8 nM.

CAS 127-07-1 Hydroxyurea

Hydroxyurea
(CAS: 127-07-1)

Hydroxyurea is an antineoplastic agent that inhibits DNA synthesis through the inhibition of ribonucleoside diphosphate reductase.

CAS 896705-16-1 BMH-21

BMH-21
(CAS: 896705-16-1)

BMH-21 is a potent small molecule DNA intercalator. BMH-21 binds ribosomal DNA and inhibits RNA polymerase I (Pol I) transcription.

CAS 64232-83-3 L189

L189
(CAS: 64232-83-3)

L189 is a DNA ligase I, III and IV inhibitor (IC50 values are 5, 9 and 5 μM respectively) that blocks DNA binding. L189 inhibits base excision repair (BER) and ...

BRD7116
(CAS: 329059-55-4)

BRD7116, a bis-aryl sufone with cell-non-autonomous anti-leukemia activity, competitively binds to bacterial DNA gyrase and is an inhibitor of leukemia stem cel...

CAS 1609960-31-7 TH588

TH588
(CAS: 1609960-31-7)

TH588 selectively kill U2OS and other cancer cell lines with less toxic to several primary or immortalized cells.

CAS 4533-39-5 Nitracrine

Nitracrine
(CAS: 4533-39-5)

Nitracrine, an acridine derivative, inhibits RNA synthesis and is an antitumor drug that has been used clinically for several years.

PD 121373
(CAS: 113457-06-0)

This active molecular has a Benzothiopyrano-indazole structure and the benzothiopyranoindazoles are potent inhibitors of nucleic acid synthesis, reducing both D...

CAS 1533426-72-0 SCR7

SCR7
(CAS: 1533426-72-0)

SCR7 successfully inhibits cell proliferation of MCF7, A549, HeLa, T47D, A2780, HT1080, and Nalm6 with IC50 of 40, 34, 44, 8.5, 120, 10, and 50 μM, respectively...

CAS 152247-02-4 CP 80080

CP 80080
(CAS: 152247-02-4)

CP 80080, a quinolinecarboxylic acid derivative, has been found to influencing DNA cleavage slightly and could probably be used in th anticancer studies.

Quick Inquiry

Verification code

Featured Items